Skip to main content

ROCKET PHARMACEUTICALS INC

For the period ended Mar 31, 2024. Filed May 7, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 7, 2024

RCKT$2.39-2.1%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

Page
Summary of Abbreviated Terms3
Cautionary Statement Regarding Forward-Looking Statements4
PART I - FINANCIAL INFORMATION6
Item 1.Financial Statements6
Consolidated Balance Sheets as of March 31, 2024 (unaudited) and December 31, 20236
Consolidated Statements of Operations for the three months ended March 31, 2024 and 2023 (unaudited)7
Consolidated Statements of Comprehensive Loss for the three months ended March 31, 2024 and 2023 (unaudited)8
Consolidated Statements of Stockholders’ Equity for the three months ended March 31, 2024 and 2023 (unaudited)9
Consolidated Statements of Cash Flows for the three months ended March 31, 2024 and 2023 (unaudited)10
Notes to Consolidated Financial Statements (unaudited)11
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations25
Item 3.Quantitative and Qualitative Disclosures About Market Risk39
Item 4.Controls and Procedures41
PART II - OTHER INFORMATION42
Item 1.Legal Proceedings42
Item 1A.Risk Factors42
Item 2.Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities42
Item 3.Defaults Upon Senior Securities42
Item 4.Mine Safety Disclosures42
Item 5.Other Information42
Item 6.Exhibits43
Signatures44
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.